IDH2 and glioma: Finally, recent rapid developments in deep learning and artificial intelligence have augmented the diagnostic precision of IDH mutation status in glioma, with reported pooled sensitivity and specificity of 0.88 and 0.8612, which are much higher than those in the present study12.